Patent Assignment
Reel/Frame 008605/0332
Merger
Recorded: 1997-06-10
Pages: 11
Assignor
SPECTRAGEN, INC.
Executed: 1996-10-23
Assignee
LYNX THERAPEUTICS, INC.
3832 BAY CENTER PLACE, HAYWARD, CALIFORNIA, 94545
Covered Properties
(2)
Dna Sequencing by Parallel Oligonucleotide Extensions
Patent:
5,750,341 →
Application:
08/424,663 →
Dna Sequencing by Parallel Olgonucleotide Extensions
Patent:
5,969,119 →
Application:
08/872,446 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 15, 1995
From: MACEVICZ, STEPHEN C.
To: LYNX THERAPEUTICS, INC.
Reel/Frame 007635/0916 →
Assignment of Assignor's Interest
Jan 18, 1996
From: LYNX THERAPEUTICS, INC.
To: SPECTRAGEN, INC.
Reel/Frame 007777/0020 →
Assignment of Assignor's Interest
May 13, 2005
From: LYNX THERAPEUTICS, INC.
To: SOLEXA, INC.
Reel/Frame 016547/0784 →
Case No. CO702845MEJ-Complaint Filed in the United States District Court/San Jose Division on May 31, 2007,
Nov 14, 2007
From: APPLERA CORPORATION-APPLIED BIOSYSTEMS GORUP
To: ILLUMINA, INC.; SOLEXA, INC.; MACEVICZ, STEPHEN C.
Reel/Frame 020125/0275 →